CLINICAL TRIALS PROFILE FOR GAMUNEX-C
✉ Email this page to a colleague
All Clinical Trials for GAMUNEX-C
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00115778 ↗ | Intravenous Immunoglobulin (IVIG) in Lung Transplantation | Completed | Columbia University | Phase 2 | 2005-06-01 | The purpose of this study is to determine if intravenous immunoglobulin (IVIG) can prevent bacterial infections in lung transplant patients with low serum levels of immunoglobulin. |
NCT00115778 ↗ | Intravenous Immunoglobulin (IVIG) in Lung Transplantation | Completed | Grifols Therapeutics Inc. | Phase 2 | 2005-06-01 | The purpose of this study is to determine if intravenous immunoglobulin (IVIG) can prevent bacterial infections in lung transplant patients with low serum levels of immunoglobulin. |
NCT00115778 ↗ | Intravenous Immunoglobulin (IVIG) in Lung Transplantation | Completed | Grifols Therapeutics LLC | Phase 2 | 2005-06-01 | The purpose of this study is to determine if intravenous immunoglobulin (IVIG) can prevent bacterial infections in lung transplant patients with low serum levels of immunoglobulin. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for GAMUNEX-C
Condition Name
Clinical Trial Locations for GAMUNEX-C
Trials by Country
Clinical Trial Progress for GAMUNEX-C
Clinical Trial Phase
Clinical Trial Sponsors for GAMUNEX-C
Sponsor Name